Stock V9Z ACERAGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aceragen, Inc.

Equities

V9Z

US00445F1093

Biotechnology & Medical Research

Market Closed - Börse Stuttgart
Other stock markets
 02:03:19 2023-09-04 EDT 		5-day change 1st Jan Change
0.346 EUR +0.58% Intraday chart for Aceragen, Inc. -.--% -.--%

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.902 0.662 1.448 - - 4.862
EBITDA 1 -60.14 -56.17 -45.77 -36.63 -26.33 -19.52
EBIT 1 -60.89 -56.6 -45.89 -36.69 -26.35 -19.54
Operating Margin -6,750.55% -8,549.7% -3,168.92% - - -401.87%
Earnings before Tax (EBT) 1 -65.98 -59.88 -56.52 -112.7 98.09 -29.68
Net income 1 -65.98 -59.88 -56.52 -112.7 98.09 -23.36
Net margin -7,315.3% -9,045.47% -3,902.97% - - -480.46%
EPS 2 -57.01 -38.27 -50.36 -56.63 -9.782 -7.180
Free Cash Flow 1 -27.8 -27.52 18.64 -67.1 -13.38 2.289
FCF margin -3,082.1% -4,156.99% 1,287.38% - - 47.08%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-03-07 19-03-06 20-03-12 21-03-01 22-03-31 23-04-13
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 112 71.4 41.7 36.3 31.8 11.5
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -27.8 -27.5 18.6 -67.1 -13.4 2.29
ROE (net income / shareholders' equity) -62.5% -69.8% -214% 220% -318% -45.5%
ROA (Net income/ Total Assets) -32.9% -37% -47.6% -51% -42.6% -18%
Assets 1 200.8 162 118.7 220.8 -230.1 130
Book Value Per Share 2 74.90 40.00 -6.400 -40.50 9.480 3.240
Cash Flow per Share 2 78.30 44.70 22.90 14.80 10.50 3.300
Capex 1 0.21 0.08 0.01 0.01 - -
Capex / Sales 22.84% 11.33% 0.76% - - -
Announcement Date 18-03-07 19-03-06 20-03-12 21-03-01 22-03-31 23-04-13
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ACERAGEN, INC. Stock Aceragen, Inc.
-.--% 3.12M
MODERNA, INC. Stock Moderna, Inc.
+33.63% 50.93B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 42.12B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 13.21B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 12.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 12.16B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. V9Z Stock
  4. Financials Aceragen, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW